1. Home
  2. SBR vs ABCL Comparison

SBR vs ABCL Comparison

Compare SBR & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sabine Royalty Trust

SBR

Sabine Royalty Trust

HOLD

Current Price

$67.42

Market Cap

1.1B

Sector

Energy

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.55

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBR
ABCL
Founded
1982
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SBR
ABCL
Price
$67.42
$3.55
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.75
AVG Volume (30 Days)
39.6K
3.6M
Earning Date
02-27-2026
11-06-2025
Dividend Yield
7.61%
N/A
EPS Growth
N/A
N/A
EPS
5.44
N/A
Revenue
$83,430,550.00
$35,325,000.00
Revenue This Year
N/A
$25.45
Revenue Next Year
N/A
$10.07
P/E Ratio
$12.49
N/A
Revenue Growth
N/A
7.17
52 Week Low
$58.25
$1.89
52 Week High
$84.39
$6.52

Technical Indicators

Market Signals
Indicator
SBR
ABCL
Relative Strength Index (RSI) 31.22 40.75
Support Level $66.81 $3.32
Resistance Level $72.69 $3.86
Average True Range (ATR) 2.22 0.19
MACD -0.98 0.04
Stochastic Oscillator 5.29 37.96

Price Performance

Historical Comparison
SBR
ABCL

About SBR Sabine Royalty Trust

Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: